Investigator Initiated Trials

Investigator Initiated Trials (IITs) are research studies led by individual researchers or healthcare professionals rather than pharmaceutical companies. These trials aim to explore new treatments, drugs, or methods of care based on the investigator's insights and hypotheses. The investigator designs the study, determines how to conduct it, and often seeks funding from grants or institutional support. IITs are valuable because they can address specific scientific questions or patient needs that may not be prioritized by larger companies, potentially leading to innovative therapies and better patient outcomes.